Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Covered Calls

Jazz Pharmaceuticals plc - Ordinary Shares covered calls A specialty pharmaceutical company, which is focused on developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

You can sell covered calls on Jazz Pharmaceuticals plc - Ordinary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for JAZZ (prices last updated Mon 12:25 PM ET):

Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
105.99 -0.91 105.87 106.12 252K 14 6.6
Covered Calls For Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jul 18 105 3.10 103.02 1.9% 36.5%
Aug 15 105 5.30 100.82 4.1% 31.8%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.